The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics ...
12d
Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program
Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS ...
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research. The study, published in Science Advances by Dr. Simon Baker and colleagues at the ...
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research funded by Kidney Research UK and York Against Cancer. The study, published in Science ...
When Tim Tavender developed a common virus, he had no idea it was the start of what would later become a cancer diagnosis. The 51-year-old from Southampton became ill with BK virus, also known as ...
BK virus (BKV) is an opportunistic pathogen that poses a significant risk to kidney transplant recipients. Often latent in healthy individuals, the virus may reactivate under intensive ...
A empresa anunciou hoje o fechamento de um financiamento adicional de US$ 11 milhões, elevando o capital total levantado para ...
CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has raised an $8M ...
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research funded by Kidney Research UK and York Against Cancer. The study, published in Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results